Cross-National Survey of Pharmaceutical Diversion U.S.
Steven P. Kurtz, Principal Investigator
Mance Buttram, Co-Investigator
Yamilka Stivers, Project Director
The abuse and diversion of prescription opioid analgesics is a substantial and growing public health problem. This study was designed to collect national surveillance data on the nature and extent of pharmaceutical diversion from a network of law enforcement and regulatory agencies. The study involves approximately 250 diversion investigators in 49 states, including rural, suburban, and urban areas. On a quarterly basis, investigators are sent a questionnaire which elicits information on new diversion cases involving targeted prescription opioids (buprenorphine, fentanyl, hydrocodone, hydromorphone, methadone, morphine, oxycodone, oxymorphone, tramadol, tapentadol) as well as prescription stimulants. This study forms part of the Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS®) System, operated by Denver Health and Hospital Authority. RADARS System surveillance programs are designed to target geographically and epidemiologically diverse segments of the US population at risk for abuse, misuse and diversion of prescription medications.
- Abuse and Diversion of Immediate Release Opioid Analgesics as Compared to Extended Release Formulations in the United States
- Effect of Abuse-Deterrent Formulation of OxyContin
- Prescription Drugs Purchased Through the Internet: Who are the End Users?
- Characteristics of Prescription Opioid Abuse in the United States and Canada
- Alternative Routes of Administration and Risk for HIV among Prescription Opioid Abusers
- Patterns of prescription opioid abuse and co-morbidity in an aging treatment population
- Mechanisms of diversion among prescription opioid abusers
- The changing face of heroin use in the United States: A retrospective analysis of the past 50 years
- Factors contributing to the rise of buprenorphine misuse: 2008-2013
- Reductions in prescription opioid diversion following recent legislative interventions in Florida
- Abuse and diversion of buprenorphine sublingual tablets and film
- Factors influencing the selection of hydrocodone and oxycodone as primary opioids in substance abusers seeking treatment in the United States